Silan, Jennifer .
HRN: 23-68-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2023
CEFUROXIME 1.5GM (VIAL)
09/12/2023
09/13/2023
IV
1.5g
Q8H
S/p CS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes